These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9528836)

  • 21. Expression of activated gelatinase in human invasive breast carcinoma.
    Brown PD; Bloxidge RE; Anderson E; Howell A
    Clin Exp Metastasis; 1993 Mar; 11(2):183-9. PubMed ID: 8444010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status.
    Mäkelä M; Salo T; Uitto VJ; Larjava H
    J Dent Res; 1994 Aug; 73(8):1397-406. PubMed ID: 8083435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localisation of gelatinase activity in epidermal hoof lamellae by in situ zymography.
    Mungall BA; Pollitt CC; Collins R
    Histochem Cell Biol; 1998 Nov; 110(5):535-40. PubMed ID: 9826133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
    Clegg PD; Coughlan AR; Riggs CM; Carter SD
    Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2.
    Todor DR; Lewis I; Bruno G; Chyatte D
    Stroke; 1998 Aug; 29(8):1580-3. PubMed ID: 9707196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).
    Hayashi T; Fleming MV; Stetler-Stevenson WG; Liotta LA; Moss J; Ferrans VJ; Travis WD
    Hum Pathol; 1997 Sep; 28(9):1071-8. PubMed ID: 9308732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization.
    Miyajima Y; Nakano R; Morimatsu M
    Ann Otol Rhinol Laryngol; 1995 Sep; 104(9 Pt 1):678-84. PubMed ID: 7661515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
    Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
    Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
    Kubota T; Kubota E; Matsumoto A; Kawai Y; Saito H; Mikuni-Takagaki Y; Sato S
    Eur J Oral Sci; 1998 Dec; 106(6):992-8. PubMed ID: 9879910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
    Murray GI; Duncan ME; O'Neil P; McKay JA; Melvin WT; Fothergill JE
    J Pathol; 1998 Jul; 185(3):256-61. PubMed ID: 9771478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.
    Liokumovich P; Goldberg I; Davidson B; Gotlieb WH; Zahavi T; Ben-Baruch G; Reder I; Kopolovic J
    J Clin Pathol; 1999 Mar; 52(3):198-202. PubMed ID: 10450179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma.
    Talvensaari-Mattila A; Pääkkö P; Höyhtyä M; Blanco-Sequeiros G; Turpeenniemi-Hujanen T
    Cancer; 1998 Sep; 83(6):1153-62. PubMed ID: 9740080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro.
    Tetlow LC; Harper N; Dunningham T; Morris MA; Bertfield H; Woolley DE
    Ann Rheum Dis; 1998 Jan; 57(1):25-32. PubMed ID: 9536819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer.
    Duffy MJ; Blaser J; Duggan C; McDermott E; O'Higgins N; Fennelly JJ; Tschesche H
    Br J Cancer; 1995 May; 71(5):1025-8. PubMed ID: 7734294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of MT1-MMP mRNA expression in breast cancer.
    Mimori K; Ueo H; Shirasaka C; Mori M
    Oncol Rep; 2001; 8(2):401-3. PubMed ID: 11182063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
    Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
    Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression.
    Lee KS; Rha SY; Kim SJ; Kim JH; Roh JK; Kim BS; Chung HC
    Clin Exp Metastasis; 1996 Nov; 14(6):512-9. PubMed ID: 8970581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors.
    Gokaslan ZL; Chintala SK; York JE; Boyapati V; Jasti S; Sawaya R; Fuller G; Wildrick DM; Nicolson GL; Rao JS
    Clin Exp Metastasis; 1998 Nov; 16(8):721-8. PubMed ID: 10211985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of an endogenous metalloproteinase in human vitreous.
    Brown D; Hamdi H; Bahri S; Kenney MC
    Curr Eye Res; 1994 Sep; 13(9):639-47. PubMed ID: 7805394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma.
    Kurizaki T; Toi M; Tominaga T
    Oncol Rep; 1998; 5(3):673-7. PubMed ID: 9538174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.